Osteri 600mcg Injection 2.4ml
By Osteri
Rx
2ml Injection in a Vial

Composition
Teriparatide(600mcg)

Manufacturer - Emcure Pharmaceuticals Ltd
255/2, Hinjawadi, Pune - 411057, India

Expires on or after
June, 2026

liver
When it comes to the safety advice regarding the liver and Osteri 600mcg Injection 2.4ml, it's important to note that there is limited information available specifically for patients with liver disease. Therefore, it is crucial to consult with your doctor before using Osteri 600mcg Injection 2.4ml, especially if you have any existing liver issues. Your doctor will be able to provide you with the necessary guidance and make an informed decision based on your individual health condition.

kidney
Osteri 600mcg Injection 2.4ml requires caution in patients with kidney disease. Dose adjustment may be necessary. Avoid use in severe kidney disease. Consult your doctor for guidance.

alcohol
When taking Osteri 600mcg Injection 2.4ml, it is important to be cautious when drinking alcohol. Please consult your doctor regarding alcohol consumption while on this medication.

driving
When taking Osteri 600mcg Injection 2.4ml, be cautious while driving as it may reduce alertness, affect vision, or cause drowsiness and dizziness. Avoid driving if experiencing these symptoms.

pregnancy
Osteri 600mcg Injection 2.4ml may not be safe during pregnancy. Animal studies have shown potential harm to the developing baby. Your doctor will assess the risks and benefits before prescribing this medication. Please consult your doctor for advice.

breastfeeding
Information on the safety of Osteri 600mcg Injection 2.4ml during breastfeeding is not available. It is advised to consult your doctor before using this medication while breastfeeding.
Habit Forming | No |
Chemical Class | Parathyroid Hormone Analogs |
Therapeutic Class | - |
Action Class | Bone formation stimulator -PTH analogue |
₹10848
Inclusive of all taxes
Content verified by

Dr. Abdullah Khan
MBBS - General Medicine
Last update on 01-Oct-2024